Hiroyuki Oka

Identification of the small molecule compound which induces hepatic differentiation of human mesenchymal stem cells

Y. Matsuzaki, K. Kanki, M. Morimoto, 2015, Regenerative therapy.

Hepatic cell sheets engineered from human mesenchymal stem cells with a single small molecule compound IC-2 ameliorate acute liver injury in mice

M. Morimoto, G. Shiota, Yohei Kono, 2018, Regenerative therapy.

A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.

M. Morimoto, G. Shiota, Y. Umekita, 2017, Anticancer research.

Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets

M. Osaki, M. Morimoto, G. Shiota, 2019, Scientific Reports.

Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets

M. Osaki, M. Morimoto, G. Shiota, 2019, Scientific Reports.

Wnt/Beta-Catenin Signal Inhibitor HC-1 Sensitizes Oral Squamous Cell Carcinoma Cells to 5-Fluorouracil through Reduction of CD44-Positive Population

K. Kanki, M. Morimoto, K. Ryoke, 2016, Yonago acta medica.

WNT/β‐catenin signal inhibitor IC‐2–derived small‐molecule compounds suppress TGF‐β1–induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signalling

H. Isomoto, T. Takata, M. Morimoto, 2020, Clinical and experimental pharmacology & physiology.